• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Cost-control programs boost OEC earnings

Article

OEC Medical Systems reported a strong increase in net income forits 1995 fiscal year (end-December), although revenues were uponly slightly compared with 1994. OEC, of Salt Lake City, attributedthe earnings growth to improved profit margins that resulted

OEC Medical Systems reported a strong increase in net income forits 1995 fiscal year (end-December), although revenues were uponly slightly compared with 1994. OEC, of Salt Lake City, attributedthe earnings growth to improved profit margins that resulted fromcost-control programs.

For the year, OEC had revenues of $101.5 million, up 3% comparedwith $98.2 million in sales the year before. The company saidinternational sales were a bright spot, as it saw a 125% increasein revenues. In the U.S., however, the ongoing consolidation ofthe healthcare industry hurt sales. Orders in 1995 were levelwith those of 1994, but higher discounting resulted in lower revenues,according to OEC chief executive Ruediger Naumann-Etienne.

Net income for the year increased sharply. OEC registered earningsof $11.8 million, up 36% over the $8.7 million reported in theyear before. Naumann-Etienne said operating profit increased asthe company focused on improving manufacturing efficiencies andon controlling costs.

For the fourth quarter of 1995, OEC had net income of $3.4million on sales of $27.1 million, compared with net income of$3.1 million and sales of $28.2 million in the fourth quarterof 1994.

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.